The data presented in the current study suggest that monogenic DNA methylation alterations are not a major contributing factor in FH in our cohort and thus are unlikely to be a common contributing factor to the FH phenotype in FH mutation-negative patients. The gene discussed is FH; the disease is familial hyperaldosteronism.